Fact CheckerSign in

NCT02391519Recruiting

Effects of High Altitude on AMPK Activation

Effects of High Altitude on 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) Activation and Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Regulation

Source: ClinicalTrials.gov · Last updated 13 Feb 2026

Brief summary (registry, in English)

Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.

Status (registry)
Recruiting
Study type
Observational
Enrollment
84 (estimated)
First submitted
3 Mar 2015
Start date
Jan 2016
Primary completion date
31 Dec 2026
Lead sponsor
University of Colorado, Denver
NCT number
NCT02391519

What you commit to

  • Study type: Observational
  • Planned participants: 84
  • From Jan 2016 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Women will be excluded if there are co-existing medical diagnoses that are known to affect vascular parameters (i.e., diabetes mellitus, gestational diabetes, any hypertensive disorder of pregnancy, or a current smoker).

Other

  • Women with multiple gestations and preterm deliveries will also be excluded.

Who the study is looking for

  • Women scheduled for cesarean delivery at University of Colorado Hospital (Denver, 1600 m) and St. Anthony's Summit Medical Center (Summit County, 3000 m)
  • Cesarean delivery at a prescheduled time without any labor, typically at 39 weeks gestation

Age in the registry: 18 years to 45 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Colorado Denver - Anschutz Medical Campus
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.